379 related articles for article (PubMed ID: 17917828)
21. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
22. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
[TBL] [Abstract][Full Text] [Related]
23. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
[TBL] [Abstract][Full Text] [Related]
24. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
[TBL] [Abstract][Full Text] [Related]
26. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
[TBL] [Abstract][Full Text] [Related]
27. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Berger AC; Watson JC; Ross EA; Hoffman JP
Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
[TBL] [Abstract][Full Text] [Related]
28. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; DomÃnguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
29. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
[TBL] [Abstract][Full Text] [Related]
30. The impact of the ratio of positive to total lymph nodes examined and outcome in colorectal cancer.
Ng M; Roy-Chowdhury S; Lum SS; Morgan JW; Wong JH
Am Surg; 2009 Oct; 75(10):873-6. PubMed ID: 19886125
[TBL] [Abstract][Full Text] [Related]
31. The relationship between involved lymph nodes, metastatic nest diameters and prognosis in colorectal cancer.
Mokarian F; Sanei MH; Chehrei A; Nurozi V; Nurozi AA
J Gastrointestin Liver Dis; 2008 Sep; 17(3):305-8. PubMed ID: 18836624
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
33. Lymph node evaluation in colorectal cancer patients: a population-based study.
Baxter NN; Virnig DJ; Rothenberger DA; Morris AM; Jessurun J; Virnig BA
J Natl Cancer Inst; 2005 Feb; 97(3):219-25. PubMed ID: 15687365
[TBL] [Abstract][Full Text] [Related]
34. Variance of surgeons versus pathologists in staging of colorectal cancer.
Jha MK; Corbett WA; Wilson RG; Koreli A; Papagrigoriadis S
Minerva Chir; 2006 Oct; 61(5):385-91. PubMed ID: 17159746
[TBL] [Abstract][Full Text] [Related]
35. Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.
Cianchi F; Messerini L; Comin CE; Boddi V; Perna F; Perigli G; Cortesini C
Dis Colon Rectum; 2007 Sep; 50(9):1332-41. PubMed ID: 17429709
[TBL] [Abstract][Full Text] [Related]
36. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
[TBL] [Abstract][Full Text] [Related]
37. Number of lymph nodes examined and its impact on colorectal cancer staging.
Kim J; Huynh R; Abraham I; Kim E; Kumar RR
Am Surg; 2006 Oct; 72(10):902-5. PubMed ID: 17058731
[TBL] [Abstract][Full Text] [Related]
38. Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer.
Kotake K; Honjo S; Sugihara K; Hashiguchi Y; Kato T; Kodaira S; Muto T; Koyama Y
Jpn J Clin Oncol; 2012 Jan; 42(1):29-35. PubMed ID: 22102737
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic value of lymph node ratio in survival of patients with stage III rectal cancer].
Zhu XW; Wu CS; Yuan SC
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):506-9. PubMed ID: 22967468
[TBL] [Abstract][Full Text] [Related]
40. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]